Ocugen Debt to Equity Ratio Analysis

Ocugen Inc (OCGN)

0.9086 +0.01 (+0.85%) USD | NASDAQ | Nov 22, 10:59

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2013. Upgrade now.

Date	Value
September 30, 2024	0.0711
June 30, 2024	0.1688
March 31, 2024	0.0935
December 31, 2023	0.069
September 30, 2023	0.0475
June 30, 2023	0.039
March 31, 2023	0.0305
December 31, 2022	0.0309
September 30, 2022	0.0238
June 30, 2022	0.0153
March 31, 2022	0.0132
December 31, 2021	0.0179
September 30, 2021	0.0158
June 30, 2021	0.0144
March 31, 2021	0.0447
December 31, 2020	0.0955
September 30, 2020	0.2188
June 30, 2020	0.4163
March 31, 2020	0.2166
December 31, 2019	0.0973
September 30, 2019	-0.0808
June 30, 2019	0.00

Date	Value
March 31, 2019	0.00
December 31, 2018	0.00
September 30, 2018	0.00
June 30, 2018	0.00
March 31, 2018	-0.0022
December 31, 2017	-0.0158
September 30, 2017	-0.0673
June 30, 2017	0.5831
March 31, 2017	0.0882
December 31, 2016	0.0561
September 30, 2016	0.2247
June 30, 2016	0.0817
March 31, 2016	0.0582
December 31, 2015	0.0477
September 30, 2015	0.0412
June 30, 2015	0.0373
March 31, 2015	0.0339
December 31, 2014	0.0323
September 30, 2014	0.1152
June 30, 2014	0.00
March 31, 2014
December 31, 2013	0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

0.0132

Minimum

Mar 2022

0.4163

Maximum

Jun 2020

0.087

Average

0.0461

Median

Debt to Equity Ratio Benchmarks

Cytokinetics Inc	-47.16
Scholar Rock Holding Corp	--
Mirum Pharmaceuticals Inc	1.326
SpringWorks Therapeutics Inc	0.00
NeuroBo Pharmaceuticals Inc	--

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly)	61.94M
Total Liabilities (Quarterly)	21.31M
Shareholders Equity (Quarterly)	40.63M
Current Ratio	2.580
Net Debt Paydown Yield	-0.01%